Abstract: Embodiments of the present disclosure provide a system for seamless discharge of patients from hospitals. A centralized electronically interconnected cloud-based system is described. The system provides Intelligent Patient Review which enables an Artificial Intelligence (AI) based analysis of patient profile inter relation between Diagnosis, Medication and Labs to alert diagnosis and medication errors. The system further provides a mechanism for hospitals to push patients' profiles from Electronic Health Record (EHR) systems and recommend the relevant care providers and broadcast the patient discharge readiness.

Abstract: A device receives historical application creation data that includes data associated with creation of a plurality of applications, and processes the historical application creation data, with one or more data processing techniques, to generate processed historical application creation data. The device trains a machine learning model, with the processed historical application creation data, to generate a trained machine learning model, and receives new application data associated with a new application to be created. The device processes the new application data, with the trained machine learning model, to generate one or more predictions associated with the new application, and performs one or more actions based on the one or more predictions associated with the new application.

Abstract: A device receives historical application creation data that includes data associated with creation of a plurality of applications, and processes the historical application creation data, with one or more data processing techniques, to generate processed historical application creation data. The device trains a machine learning model, with the processed historical application creation data, to generate a trained machine learning model, and receives new application data associated with a new application to be created. The device processes the new application data, with the trained machine learning model, to generate one or more predictions associated with the new application, and performs one or more actions based on the one or more predictions associated with the new application.

Abstract: Systems and methods for secure distributed crowdfunding are provided. The one or more databases contain a plurality of user characteristics and crowdfunding proposals. The plurality of user characteristics includes one or more of transaction frequency, likelihood of interest, and transaction history. One or more processors may be configured to operate a recommendation engine to identify a crowdfunding proposal for presentation based on one or more of the plurality of user characteristics and the application of one or more thresholds to the plurality of user characteristics. The identified crowdfunding proposal may be transmitted to a client device associated with the user along with one or more offers for contribution. Upon receipt of the user's acceptance of an offer to contribute from the client device, a smart contract is generated based on the offer to contribute and at least one of account data and transaction data associated with the user.

Abstract: A device receives historical application creation data that includes data associated with creation of a plurality of applications, and processes the historical application creation data, with one or more data processing techniques, to generate processed historical application creation data. The device trains a machine learning model, with the processed historical application creation data, to generate a trained machine learning model, and receives new application data associated with a new application to be created. The device processes the new application data, with the trained machine learning model, to generate one or more predictions associated with the new application, and performs one or more actions based on the one or more predictions associated with the new application.

Abstract: The present invention provides compounds of formula (I), (II) or (IV), or pharmaceutically acceptable salts and solvates thereof, which are useful as inhibitors of the Hepatitis C virus (HCV) protease enzyme and are also useful for the treatment of HCV infections in HCV-infected mammals, including humans. The present invention also provides pharmaceutical compositions comprising compounds of formula (I), (II) or (IV), their pharmaceutically acceptable salts and solvates. Furthermore, the present invention provides intermediate compounds and methods useful in the preparation of compounds of formulas (I), (II) and (IV).